EXACT Common Stock vs Total Current Assets Analysis
EXAS Stock | USD 53.34 0.66 1.22% |
EXACT Sciences financial indicator trend analysis is much more than just examining EXACT Sciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether EXACT Sciences is a good investment. Please check the relationship between EXACT Sciences Common Stock and its Total Current Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.
Common Stock vs Total Current Assets
Common Stock vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of EXACT Sciences Common Stock account and Total Current Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between EXACT Sciences' Common Stock and Total Current Assets is 0.79. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of EXACT Sciences, assuming nothing else is changed. The correlation between historical values of EXACT Sciences' Common Stock and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of EXACT Sciences are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Common Stock i.e., EXACT Sciences' Common Stock and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.79 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Common Stock
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from EXACT Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into EXACT Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.At this time, EXACT Sciences' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 2.5 M in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (1.1 K).
2021 | 2022 | 2023 | 2024 (projected) | Non Recurring | 20.2M | 16.0M | 14.4M | 13.7M | Reconciled Depreciation | 180.3M | 197.6M | 206.6M | 131.5M |
EXACT Sciences fundamental ratios Correlations
Click cells to compare fundamentals
EXACT Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EXACT Sciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 3.5B | 4.9B | 6.7B | 6.2B | 6.5B | 6.8B | |
Total Stockholder Equity | 2.3B | 2.8B | 3.4B | 3.0B | 3.1B | 3.3B | |
Net Debt | 769.0M | (27.1M) | 2.0B | 2.2B | 1.9B | 2.0B | |
Cash | 177.3M | 1.5B | 315.5M | 242.5M | 605.4M | 635.6M | |
Other Assets | 20.3M | 63.8M | 74.6M | 36.7M | 42.2M | 44.3M | |
Cash And Short Term Investments | 323.7M | 1.8B | 1.0B | 632.1M | 777.6M | 816.5M | |
Common Stock Shares Outstanding | 131.3M | 151.1M | 171.3M | 176.4M | 180.1M | 189.2M | |
Liabilities And Stockholders Equity | 3.5B | 4.9B | 6.7B | 6.2B | 6.5B | 6.8B | |
Other Stockholder Equity | 3.4B | 4.8B | 6.0B | 6.3B | 6.6B | 6.9B | |
Total Liab | 1.2B | 2.1B | 3.3B | 3.2B | 3.3B | 3.5B | |
Total Current Assets | 557.0M | 2.2B | 1.4B | 982.3M | 1.2B | 1.3B | |
Other Current Liab | 8.5M | 38.3M | 31.0M | 306.4M | 14.8M | 20.2M | |
Total Current Liabilities | 236.5M | 575.8M | 517.1M | 412.7M | 514.7M | 540.4M | |
Property Plant And Equipment Net | 581.8M | 576.6M | 754.5M | 851.8M | 842.1M | 884.2M | |
Retained Earnings | (1.1B) | (2.0B) | (2.6B) | (3.3B) | (3.5B) | (3.3B) | |
Accounts Payable | 26.0M | 35.7M | 67.8M | 74.9M | 78.8M | 82.8M | |
Non Current Assets Total | 2.9B | 2.7B | 5.3B | 5.2B | 5.3B | 5.5B | |
Non Currrent Assets Other | 20.3M | (193.1M) | (451.3M) | (425.5M) | (287.5M) | (273.2M) | |
Common Stock Total Equity | 1.5M | 1.6M | 1.7M | 1.8M | 2.0M | 2.1M | |
Other Current Assets | 40.9M | 33.2M | 74.1M | 73.9M | 85.6M | 89.9M | |
Property Plant And Equipment Gross | 581.8M | 576.6M | 754.5M | 851.8M | 1.3B | 1.3B | |
Accumulated Other Comprehensive Income | (100K) | 526K | (1.4M) | (5.2M) | 1.4M | 1.5M | |
Common Stock | 1.5M | 1.6M | 1.7M | 1.8M | 1.8M | 1.9M | |
Intangible Assets | 1.1B | 848.4M | 2.1B | 2.0B | 1.9B | 2.0B | |
Property Plant Equipment | 455.3M | 450.7M | 754.5M | 684.8M | 787.5M | 826.8M | |
Good Will | 1.2B | 1.2B | 2.3B | 2.3B | 2.4B | 2.5B | |
Other Liab | 28.1M | 61.6M | 417.8M | 345.1M | 396.8M | 416.7M | |
Short Term Investments | 146.4M | 348.7M | 715.0M | 389.6M | 172.3M | 222.6M | |
Non Current Liabilities Total | 981.2M | 1.5B | 2.8B | 2.8B | 2.8B | 3.0B | |
Current Deferred Revenue | 193.3M | 233.6M | 398.6M | 3.1M | 341.7M | 358.8M | |
Short Long Term Debt Total | 946.3M | 1.5B | 2.4B | 2.4B | 2.6B | 2.7B | |
Long Term Debt | 827.6M | 1.3B | 2.2B | 2.2B | 2.3B | 2.4B | |
Net Tangible Assets | (58.7M) | 737.4M | (1.0B) | 697.1M | 627.4M | 658.8M | |
Retained Earnings Total Equity | (1.1B) | (2.0B) | (2.6B) | (3.3B) | (2.9B) | (2.8B) | |
Long Term Debt Total | 4.3M | 688.8M | 827.6M | 2.2B | 2.5B | 2.6B | |
Capital Surpluse | 3.4B | 4.8B | 6.0B | 6.3B | 7.3B | 7.6B | |
Inventory | 61.7M | 92.3M | 105.0M | 118.3M | 127.5M | 133.8M | |
Non Current Liabilities Other | 34.9M | 61.6M | 417.8M | 352.5M | 336.0M | 352.8M | |
Short Term Debt | 8.7M | 268.3M | 19.7M | 28.4M | 79.4M | 83.3M |
EXACT Sciences Investors Sentiment
The influence of EXACT Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in EXACT. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to EXACT Sciences' public news can be used to forecast risks associated with an investment in EXACT. The trend in average sentiment can be used to explain how an investor holding EXACT can time the market purely based on public headlines and social activities around EXACT Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
EXACT Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for EXACT Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average EXACT Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on EXACT Sciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EXACT Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EXACT Sciences' short interest history, or implied volatility extrapolated from EXACT Sciences options trading.
Pair Trading with EXACT Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EXACT Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXACT Sciences will appreciate offsetting losses from the drop in the long position's value.Moving together with EXACT Stock
0.64 | VALN | Valneva SE ADR | PairCorr |
Moving against EXACT Stock
0.5 | TIL | Instil Bio | PairCorr |
The ability to find closely correlated positions to EXACT Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EXACT Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EXACT Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EXACT Sciences to buy it.
The correlation of EXACT Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EXACT Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EXACT Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EXACT Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for EXACT Stock analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.31) | Revenue Per Share 13.998 | Quarterly Revenue Growth 0.058 | Return On Assets (0.03) | Return On Equity (0.08) |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.